Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09WND
|
||||
| Former ID |
DIB006639
|
||||
| Drug Name |
TETRAPLATIN TETRANITRATE
|
||||
| Synonyms |
BBR-3464; Tetraplatin tetranitrate < Prop INN >; Hexaamminedichlorobis[mu-(1,6-hexanediamine-kappaN:kappaN')]triplatinum(4+) tetranitrate
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 2 | [1] | ||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Binder | [2] | |
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT00014547) BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment. U.S. National Institutes of Health. | ||||
| REF 2 | Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines. Anticancer Drugs. 1993 Apr;4(2):251-8. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.